معرفی
Professor Sejal Saglani is a leading academic in Paediatric Respiratory Medicine at Imperial College London's National Heart & Lung Institute (NHLI). She holds honorary consulting roles at the Royal Brompton Hospital and chairs the European Respiratory Society's Paediatric Asthma and Allergy Group. Her research focuses on early-life mechanisms of asthma and preschool wheeze, integrating clinical and translational approaches.
Education: MBBS from University of Leicester, postgraduate asthma research fellowship at NHLI, and Wellcome Intermediate Clinical Fellowship. She has secured grants from MRC, NIHR, and Wellcome Trust. Awards include the ERS Romain Pauwels Award (2015) and Young Investigator Award (2009).
Research Interests: Mechanisms of asthma onset in early childhood, biomarker-driven therapies, airway remodelling, and microbiome influences. Her lab uses neonatal mouse models and human airway samples to bridge preclinical and clinical studies, with direct application to clinical trials like the TREAT trial comparing mepolizumab and omalizumab.
Grants & Awards: NIHR Career Development Fellowship (2015), MRC New Investigator Award (2012), Wellcome Trust support (2008), and British Lung Foundation Fellowship (2007). She also holds editorial roles at Clinical and Experimental Allergy.
Labs & Affiliations: Leads the Paediatric Severe Asthma Group within the Inflammation, Repair and Development Section. Collaborates with the Lloyd Lab and Imperial NHLI teams. Active in the Immuno-Pathology Network and Microbiome Network. Her work emphasizes translational research, including contactless monitoring devices (e.g., Albus Home) and telehealth interventions for asthma management.